As a result, overexpression of MARCH5 attenuates HBV-induced hepatic inflammation and mitophagy, and MARCH5 expression is positively correlated with the survival of HCC patients [180]. This evidence concerns the gene MARCHF5 and hepatocellular carcinoma.